These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16938650)

  • 21. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
    Huang H; Shiffman ML; Cheung RC; Layden TJ; Friedman S; Abar OT; Yee L; Chokkalingam AP; Schrodi SJ; Chan J; Catanese JJ; Leong DU; Ross D; Hu X; Monto A; McAllister LB; Broder S; White T; Sninsky JJ; Wright TL
    Gastroenterology; 2006 May; 130(6):1679-87. PubMed ID: 16697732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
    Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
    J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications.
    Lee CM; Lu SN; Hung CH; Tung WC; Wang JH; Tung HD; Chen CH; Hu TH; Changchien CS; Chen WJ
    Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):767-74. PubMed ID: 16443243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.
    Askar E; Bregadze R; Mertens J; Schweyer S; Rosenberger A; Ramadori G; Mihm S
    J Med Virol; 2009 Jul; 81(7):1204-11. PubMed ID: 19475618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.
    Kamar N; Rostaing L; Sandres-Saune K; Selves J; Barthe C; Dubois M; Alric L; Durand D; Izopet J
    J Med Virol; 2005 Aug; 76(4):482-8. PubMed ID: 15977245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mannose-binding lectin gene polymorphisms are not associated with susceptibility to hepatitis C virus infection in the Brazilian Amazon region.
    Vallinoto AC; da Silva RF; Hermes RB; Amaral IS; Miranda EC; Barbosa MS; Moia Lde J; Conde SR; Soares Mdo C; Lemos JA; Machado LF; Ishak MO; Ishak R
    Hum Immunol; 2009 Sep; 70(9):754-7. PubMed ID: 19540295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
    Muir AJ; Sylvestre PB; Rockey DC
    J Viral Hepat; 2006 May; 13(5):322-8. PubMed ID: 16637863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The association of genetic polymorphism of dendritic cell-specific ICAM-grabbing nonintegrin and hepatitis C infection].
    Wang M; Han HX; Lu J; Liu SY; Jiang Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):645-8. PubMed ID: 19785948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of polymorphism of transforming growth factor beta1 gene on HBV-induced liver cirrhosis].
    Yang ZX; Wang H; Gao CF; Xu LL; Zhao WJ
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1021-6. PubMed ID: 16029542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis.
    Watson MW; Jaksic A; Price P; Cheng W; McInerney M; French MA; Fisher S; Lee S; Flexman JP
    J Infect Dis; 2003 Nov; 188(10):1533-6. PubMed ID: 14624379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
    Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
    J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
    Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetics factors determining predisposition to chronic course of virus hepatitis and fibrosis in liver].
    Goncharova IA; Beloborodova EV; Freĭdin MB; Beloborodova EI; Chernogoriuk GE; Puzyrev VP
    Mol Biol (Mosk); 2008; 42(2):238-41. PubMed ID: 18610831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
    Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C.
    Patel K; Norris S; Lebeck L; Feng A; Clare M; Pianko S; Portmann B; Blatt LM; Koziol J; Conrad A; McHutchison JG
    Hepatology; 2006 Feb; 43(2):241-9. PubMed ID: 16440356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.